David Rescott

Stock Analyst at Baird

(3.54)
# 859
Out of 5,245 analysts
86
Total ratings
56.06%
Success rate
4.09%
Average return

Stocks Rated by David Rescott

Boston Scientific
May 19, 2026
Maintains: Outperform
Price Target: $78$75
Current: $57.78
Upside: +29.80%
LivaNova
May 7, 2026
Maintains: Outperform
Price Target: $78$76
Current: $73.83
Upside: +2.94%
Edwards Lifesciences
Apr 24, 2026
Maintains: Neutral
Price Target: $85$87
Current: $85.78
Upside: +1.42%
Intuitive Surgical
Apr 22, 2026
Maintains: Outperform
Price Target: $575$610
Current: $438.10
Upside: +39.24%
PROCEPT BioRobotics
Mar 6, 2026
Initiates: Neutral
Price Target: $30
Current: $29.00
Upside: +3.45%
Medtronic
Feb 18, 2026
Maintains: Neutral
Price Target: $103$100
Current: $78.60
Upside: +27.23%
Penumbra
Jan 16, 2026
Downgrades: Neutral
Price Target: $345$374
Current: $328.69
Upside: +13.79%
SI-BONE
Dec 18, 2025
Maintains: Buy
Price Target: $21$23
Current: $14.68
Upside: +56.68%
Haemonetics
Dec 15, 2025
Maintains: Outperform
Price Target: $87$99
Current: $65.49
Upside: +51.17%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111$110
Current: $64.17
Upside: +71.42%